Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D08WHV
|
|||
Former ID |
DNC002497
|
|||
Drug Name |
5-N-Allyl-Arginine
|
|||
Synonyms |
5-N-ALLYL-ARGININE; ARV; AC1NRA56; DB03892; N-[(1Z)-amino{[(4S)-4-amino-4-carboxybutyl]amino}methylidene]prop-2-en-1-aminium
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C9H19N4O2+
|
|||
Canonical SMILES |
C=CCNC(=[NH+]CCCC(C(=O)O)N)N
|
|||
InChI |
1S/C9H18N4O2/c1-2-5-12-9(11)13-6-3-4-7(10)8(14)15/h2,7H,1,3-6,10H2,(H,14,15)(H3,11,12,13)/p+1/t7-/m0/s1
|
|||
InChIKey |
ZPQWZDPOLXVMOU-ZETCQYMHSA-O
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Nitric-oxide synthase brain (NOS1) | Target Info | Inhibitor | [1] |
BioCyc | Citrulline-nitric oxide cycle | |||
KEGG Pathway | Arginine and proline metabolism | |||
Metabolic pathways | ||||
Calcium signaling pathway | ||||
Phagosome | ||||
Circadian entrainment | ||||
Long-term depression | ||||
Salivary secretion | ||||
Alzheimer's disease | ||||
Amyotrophic lateral sclerosis (ALS) | ||||
NetPath Pathway | EGFR1 Signaling Pathway | |||
Panther Pathway | CCKR signaling map ST | |||
Pathwhiz Pathway | Arginine and Proline Metabolism | |||
Reactome | ROS production in response to bacteria | |||
Nitric oxide stimulates guanylate cyclase | ||||
WikiPathways | Monoamine Transport | |||
Myometrial Relaxation and Contraction Pathways | ||||
Amyotrophic lateral sclerosis (ALS) | ||||
Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis | ||||
Spinal Cord Injury | ||||
Alzheimers Disease | ||||
Effects of Nitric Oxide | ||||
Serotonin Transporter Activity |
References | Top | |||
---|---|---|---|---|
REF 1 | How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.